• MD4011: Integrated Pathology and Clinical Medicine Part 1 of 3 (Level 4; TSV)
  • MD4012: Integrated Pathology and Clinical Medicine Part 2 of 3 (Level 4; TSV)
  • MD4013: Integrated Pathology and Clinical Medicine Part 3 of 3 (Level 4; TSV)
Research Disciplines

These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU. Hover over Altmetrics badges to see social impact.

Journal Articles
Book Chapters
Other research outputs
Current Funding

Current and recent Research Funding to JCU is shown by funding source and project.

Sanofi Pasteur - Contract Research

Efficacy, Immunogenicity, and Safety Study of Clostridium difficile Toxoid Vaccine in Subjects at Risk for C. difficile Infection

Indicative Funding
$578,450 over 5 years
Clostridium difficile is a bacterial infection that can cause severe diarrhoea in people who have been exposed to the hospital environment and antibiotics. The bacteria produces a toxin, which is responsible for the clinical symptoms. Antibodies, induced by vaccination, may prevent the disease which is now amongst the leading cause of gastroenteritis in developed countries. This trial, which will enrolled 15,000 patients from around the world will measure the rate of clinical episodes of diarrhoea due to Clostridium difficile in people who have been vaccinated versus those who have received a placebo.
John McBride and Nichola Davis in collaboration with Sue Richmond (College of Medicine & Dentistry and Queensland Health)
Clostridium difficile; Vaccine; Clinical Trial

Connect with me
Share my profile
Share my profile:


Similar to me

  1. Dr Aileen Traves
    College of Medicine & Dentistry
  2. Dr Michael Inskip
    College of Healthcare Sciences
  3. Dr Anupama Bangara Kulur
    College of Public Health, Medical & Vet Sciences
  4. Dr Linton Harriss
    College of Public Health, Medical & Vet Sciences
  5. Dr Sandra Campbell
    Mt Isa Centre for Rural & Remote Health